Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
1,547
Views
0
CrossRef citations to date
0
Altmetric
COVID-19
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany
Keya Joshia Moderna, Inc., Cambridge, MA, USACorrespondence[email protected]
, Stefan Scholzb Moderna Germany GmbH, Munich, Germany
, Michael Maschioc Quadrant Health Economics Inc, Cambridge, ON, Canada
, Michele Kohlic Quadrant Health Economics Inc, Cambridge, ON, Canada
, Amy Leec Quadrant Health Economics Inc, Cambridge, ON, Canada
, Kelly Fustc Quadrant Health Economics Inc, Cambridge, ON, Canada
, Bernhard Ultschb Moderna Germany GmbH, Munich, Germany
, Nicolas Van de Veldea Moderna, Inc., Cambridge, MA, USA
& Ekkehard Becka Moderna, Inc., Cambridge, MA, USA
show all
Pages 39-50
|
Received 18 Oct 2023, Accepted 29 Nov 2023, Published online: 13 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.